DutyPills.com
Diabetes Treatment

Lantus vs generic: are they the same?

Lantus is the originator brand for the active ingredient Insulin Glargine. Once the original patent expired, authorised generic versions of the same active ingredient became available. For most users at 100 IU/mL, the practical question is: is the generic just as good, and what really differs?

What is the same

Authorised generics of Insulin Glargine contain the same active substance at the same 100 IU/mL strength as Lantus, with regulator-required bioequivalence to the originator. Clinical effect is, on average, the same. According to the prescribing information, generics meet the same regulatory standard and can substitute for the brand in most patients.

What can differ

Differences include manufacturer, country of production, excipients, tablet appearance, packaging and price. A small minority of patients react to a specific excipient that varies between manufacturers. Price is usually significantly lower for generics — often the most decisive practical difference for chronic use.

Frequently asked questions

Is generic Insulin Glargine as effective as Lantus?

For most users at 100 IU/mL, yes — authorised generics of Insulin Glargine are required to demonstrate bioequivalence to Lantus and produce the same clinical effect on average. Some users notice no difference; a few report subjective differences that are usually due to excipients or expectation.

Why does Lantus cost more than the generic?

The price difference reflects the originator's development costs, brand recognition and marketing, plus the larger volume and competition among generic manufacturers. The active ingredient Insulin Glargine itself is identical between brand and authorised generic at 100 IU/mL.

More on Lantus

The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.